Financial Contrast: Eternity Healthcare (OTCMKTS:ETAH) versus Mettler-Toledo International (NYSE:MTD)

Mettler-Toledo International (NYSE:MTD) and Eternity Healthcare (OTCMKTS:ETAH) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, valuation, profitability, institutional ownership, risk and analyst recommendations.

Earnings & Valuation

This table compares Mettler-Toledo International and Eternity Healthcare”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mettler-Toledo International	$4.03 billion	7.12	$869.19 million	$42.64	33.27
Eternity Healthcare	N/A	N/A	N/A	N/A	N/A

Mettler-Toledo International has higher revenue and earnings than Eternity Healthcare.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Mettler-Toledo International and Eternity Healthcare, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mettler-Toledo International	0	7	6	0	2.46
Eternity Healthcare	0	0	0	0	0.00

Mettler-Toledo International currently has a consensus target price of $1,420.36, indicating a potential upside of 0.13%. Given Mettler-Toledo International’s stronger consensus rating and higher probable upside, research analysts plainly believe Mettler-Toledo International is more favorable than Eternity Healthcare.

Institutional & Insider Ownership

95.1% of Mettler-Toledo International shares are owned by institutional investors. 0.7% of Mettler-Toledo International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares Mettler-Toledo International and Eternity Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mettler-Toledo International	21.91%	-1,212.14%	25.11%
Eternity Healthcare	N/A	N/A	N/A

Summary

Mettler-Toledo International beats Eternity Healthcare on 8 of the 9 factors compared between the two stocks.

About Mettler-Toledo International

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company’s retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.

About Eternity Healthcare

Eternity Healthcare, Inc. engages in the provision of stem cell storage and related medical therapies in China. Its services include cell derivation and cell banking. The company was founded on October 24, 2007 and is headquartered in Hong Kong.